IDiyas

For the Inventor, By the Inventor

Massy, France

Claude C Morel

USPTO Granted Patents = 11

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 58(Granted Patents)


Location History:

  • Massy, FR (1980 - 1982)
  • Cresly Magny les Hameaux, FR (1990)
  • Magny-les-Hameaux, FR (1986 - 1995)

Company Filing History:

goldMedal11 out of 252 
 
Synthelabo
 patents

Years Active: 1980-1995

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5418248 - 2-thienylimidazo[2,1-.beta.]benzothiazole-3-acetic acid derivatives, (1995-05-23),
2. 4977159 - 2-[(4-piperidyl)methyl]-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole (1990-12-11),
3. 4931449 - 2-((4-piperidyl)methyl)benzofuro(2,3-C)pyridine derivatives, and their (1990-06-05),
4. 4904684 - 2-(4,5-dihydro-1H-imidazol-2-yl)-1,2,4,5-tetrahydropyrrolo[3,2,1 (1990-02-27),
5. 4617313 - Alpha.sub.2 -antagonistic (1986-10-14),
6. 4567177 - Imidazoline derivatives as .alpha..sub.2 -antagonists (1986-01-28),
7. 4358451 - Pyrimido- and imidazo-pyridoindole derivatives (1982-11-09),
8. 4336256 - Pyridoindole derivatives (1982-06-22),
9. 4277476 - Derivatives of fluorenes and fluoranthenes and process for their (1981-07-07),
10. 4272539 - Pyridoindole derivatives (1981-06-09),
11. 4190657 - Naphthyridine derivatives (1980-02-26),

Title: Claude C. Morel: A Trailblazer in the World of Inventions

Introduction:

Claude C. Morel's passion for innovation and relentless drive to create have solidified his position as a trailblazer in the world of inventions. His remarkable contributions continue to inspire future generations of inventors to think outside the box and pursue their creative visions.

Latest Patents:

Claude C. Morel, based in Massy, FR, holds a total of 11 patents. His latest patents include compounds like 2-thienylimidazo[2,1-.beta.]benzothiazole-3-acetic acid derivatives and 2-[(4-piperidyl)methyl]-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole. These compounds exhibit promising potential for treating hypertension, depressive states, or anxiety states.

Career Highlights:

Claude C. Morel is a key figure at Synthelabo, where he channels his inventive spirit into groundbreaking projects. His innovative solutions have pushed the boundaries of pharmaceutical research and development, making a significant impact in the industry.

Collaborations:

Within Synthelabo, Claude C. Morel collaborates closely with esteemed colleagues such as Mireille Sevrin and Gabor I. Koletar. Together, they form a dynamic team, combining their expertise to develop cutting-edge pharmaceutical solutions that benefit society as a whole.

Conclusion:

Claude C. Morel's legacy as an inventor is characterized by his relentless pursuit of innovation and his commitment to creating solutions that improve lives. His work at Synthelabo continues to drive progress in the field of pharmaceuticals, setting a high standard for future inventors to aspire to.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…